ÂÜÀòÂÒÂ×

Malcolm Little is a seasoned investment professional with extensive experience in private equity and corporate governance. Currently serving as a Partner at Arlington Capital Partners since May 2014, Malcolm holds board positions at multiple companies including Afton Scientific, LLC, AVS Bio, Everest Clinical Research, and Grand River Aseptic Manufacturing. Previous board roles were held at Molecular Products, Ontario Systems, MicroPact, and Avalign Technologies. Prior to joining Arlington Capital Partners, Malcolm served as Vice President at Avista Capital Partners. Educational credentials include a Master in Business Administration from Harvard Business School and a Bachelor of Science in Commerce from the University of Virginia.